NewLimit

formerly New Limit

Extending human healthspan.

NewLimit is a biotech company in South San Francisco, United States, founded in 2022. It has raised $735.0M across 7 rounds, most recently a $435.0M Venture Round in June 2026.

Employees
11–50
Founded
2022
Business Model
B2B
Total Funding
$735.0M
Last Round
$435.0M Venture RoundJun 2026
Rounds
7

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 7 funding rounds and 16 investors for this company. to use credits for reveals, or explore the API.

About

NewLimit is inventing medicines to restore youthful function in old cells by reprogramming the epigenome. We leverage technologies like single cell genomics, machine learning, and high-throughput functional assays to reveal epigenetic features of aging and discover rejuvenating interventions. Our first programs target the aging liver, immune, and vascular systems as stepping stones to significantly extending human healthspan.

Funding History

Data from Indexed.vcUpdated
Venture RoundClinical Trial FinancingJun 2026
$435.0M

6 more events

  • Corporate Round20254 investors
  • Series B20256 investors
  • Series A20241 investor

Funding: Seed through Venture Round. Amounts, valuations, and investors where available.

Investors

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

  • Other ×2
  • AI/ML ×1
  • Frontend ×1
  • Marketing & SEO ×1

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Companies in related industries

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

NewLimit on Indexed.vc
<a href="https://indexed.vc/companies/newlimit"><img src="https://indexed.vc/api/badge/company/newlimit" alt="NewLimit on Indexed.vc" width="260" height="76" /></a>